Persistent parvovirus B19 infections in immunocompromised children

被引:38
作者
Flunker, G
Peters, A
Wiersbitzky, S
Modrow, S
Seidel, W
机构
[1] Ernst Moritz Arndt Univ Greifswald, Abt Virol, Inst Med Mikrobiol, D-17487 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Kindermed, Zentrum Kinder & Jugendmed, D-17487 Greifswald, Germany
[3] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-93053 Regensburg, Germany
关键词
parvovirus B19 persistence; patients with immune defect; PCR; nonstructural protein; immune response;
D O I
10.1007/s004300050063
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunocompromised patients have been shown to suffer from prolonged viral infections often without detectable immune response. Here chronic infections with low virus levels can be frequently observed. In these patients viral DNA can be detected over long periods by polymerase chain reaction (PCR). In this study parvovirus B19 presence was assessed by PCR, immunoblot and enzyme-linked immunosorbent assay in sera from children with mainly oncological and hematological diseases. In 45% of sera B19 DNA was observed. Of the children 25% had IgG antibodies to viral protein 1 and 2 (VP1/2) and 15% to nonstructural protein 1 (NS 1). In 6% of children IgM antibodies to VP1/2 were detected. These results indicate that the number of children with immune response to B19 proteins is distinctly lower than the number of children with B19 DNA. Transfusions of blood products might have been a possible route for B19 infection. Establishment and maintenance of a persistent parvovirus B19 infection with or without immune response are enhanced in the analyzed immunocompromised children in comparison with immunocompetent children. A persistence of B19 DNA was demonstrated up to 10 months in patients sera.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 37 条
[21]   CHRONIC BONE-MARROW FAILURE DUE TO PERSISTENT B19-PARVOVIRUS INFECTION [J].
KURTZMAN, GJ ;
OZAWA, K ;
COHEN, B ;
HANSON, G ;
OSEAS, R ;
YOUNG, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :287-294
[22]   IMMUNE-RESPONSE TO B19 PARVOVIRUS AND AN ANTIBODY DEFECT IN PERSISTENT VIRAL-INFECTION [J].
KURTZMAN, GJ ;
COHEN, BJ ;
FIELD, AM ;
OSEAS, R ;
BLAESE, RM ;
YOUNG, NS .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1114-1123
[23]   DETECTION OF PARVOVIRUS-B19 IN DONATED BLOOD - A MODEL SYSTEM FOR SCREENING BY POLYMERASE CHAIN-REACTION [J].
MCOMISH, F ;
YAP, PL ;
JORDAN, A ;
HART, H ;
COHEN, BJ ;
SIMMONDS, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) :323-328
[24]  
MORTIMER PP, 1983, LANCET, V2, P482
[26]  
MURRAY JC, 1993, AM J PEDIAT HEMATOL, V15, P420
[27]   PERSISTENT B19 PARVOVIRUS INFECTIONS IN HEMOPHILIC HIV-1-INFECTED PATIENTS [J].
MUSIANI, M ;
ZERBINI, M ;
GENTILOMI, G ;
RODORIGO, G ;
DEROSA, V ;
GIBELLINI, D ;
VENTUROLI, S ;
GALLINELLA, G .
JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (02) :103-108
[28]   CHARACTERIZATION OF A NESTED POLYMERASE CHAIN-REACTION ASSAY FOR DETECTION OF PARVOVIRUS B19 [J].
PATOU, G ;
PILLAY, D ;
MYINT, S ;
PATTISON, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (03) :540-546
[29]  
PETERS A, 1994, PEDIAT GRENZGEB, V32, P365
[30]   RAPID DETECTION OF HUMAN PARVOVIRUS B19 DNA BY DOT-HYBRIDIZATION AND THE POLYMERASE CHAIN-REACTION [J].
SALIMANS, MMM ;
HOLSAPPEL, S ;
VANDERIJKE, FM ;
JIWA, NM ;
RAAP, AK ;
WEILAND, HT .
JOURNAL OF VIROLOGICAL METHODS, 1989, 23 (01) :19-28